ENVB

ENVERIC BIOSCIENCES INC

ENVB·29405E505·US·Common Stock·Healthcare - Biotechnology-13D/G

ENVB (ENVERIC BIOSCIENCES INC) is held by 8 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($62,368), UBS Group AG ($7,008), JONES FINANCIAL COMPANIES LLLP ($1,880). Net institutional sentiment: Mixed.

8
Holders
Avg rating(2 Elite)
$71,363
Total Value
60% (10)
Fund Consensus
3 buying - 2 selling
ENVBSmart Money Verdict
View all
Held by 8 funds
2 elite
Who's Trading
ActivistEJEASTON JEFF7.9%May 15, 2026
ActivistMPMitchell P. Kopin5.0%Feb 2, 2026
ActivistATAdvisorShares Trust1.7%Jan 5, 2026
ActivistBLBraeden Lichti0.0%Dec 10, 2025
ActivistNINorthstrive Fund II LP0.0%Dec 10, 2025
ActivistAYAyrton Capital LLC10.0%Nov 13, 2025
ActivistMPMitchell P. Kopin0.4%Sep 24, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
32,149$62,3680.0%-35.71%
32
Increased
3,612(+24.8%)$7,0080.0%-84.62%
13
New
1,000$1,8800.0%-35.71%
17
Unchanged
51$990.0%-92.35%
0
Unchanged
1$20.0%-92.35%
0
Unchanged
1$20.0%-92.35%
0
Unchanged
1$20.0%-92.35%
0
Unchanged
1$20.0%-65.47%
0
Exited
0(-100.0%)$180.0%-85.36%
0
Exited
0(-100.0%)$8,2620.0%-46.29%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used